Top Banner
OPHTEIS ® FR PRO THAT’S RADICAL THINKING
4

OPHTEIS FR PRO THAT’S RADICAL THINKING€¦ · the use of Rayner’s Ophteis FR Pro reduces cell death by an average of 27.8%*. We’ve put a lot of fresh thinking into our new

Jun 04, 2020

Download

Documents

dariahiddleston
Welcome message from author
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
Page 1: OPHTEIS FR PRO THAT’S RADICAL THINKING€¦ · the use of Rayner’s Ophteis FR Pro reduces cell death by an average of 27.8%*. We’ve put a lot of fresh thinking into our new

OPHTEIS® FR PRO THAT’S RADICAL THINKING

Page 2: OPHTEIS FR PRO THAT’S RADICAL THINKING€¦ · the use of Rayner’s Ophteis FR Pro reduces cell death by an average of 27.8%*. We’ve put a lot of fresh thinking into our new

Containing sorbitol for unparalleled free radical scavenging

Sorbitol acts as an outstanding free radical scavenger,neutralising reactive oxygen species during surgery that causes damage to the endothelium. In fact, whencompared to market leading OVDs, studies show thatthe use of Rayner’s Ophteis FR Pro reduces cell death by an average of 27.8%*.

We’ve put a lot of fresh thinking into our newOphteis FR Pro. It’s a unique bio-engineered Visco-Surgical Device (OVD) containing free radical scavenging sorbitol – designed to deliver a new level of corneal endothelial protection from phaco induced trauma.

INTRODUCING OPHTEIS® FR PRO

PROTECTS... the endothelium throughout the phaco procedure.

The benefits of Rayner’s Ophteis FR Pro:

MAINTAINS... the integrity of the anterior chamber by increasing the volume and space.

ENABLES...the surgeon to easily manipulate and move tissue during surgery.

PROVIDES... a new level of protection and ease of use during cataract surgery.

* University of Brighton, UK, in vitro chemical and phaco free radical studies, data to be published.

Page 3: OPHTEIS FR PRO THAT’S RADICAL THINKING€¦ · the use of Rayner’s Ophteis FR Pro reduces cell death by an average of 27.8%*. We’ve put a lot of fresh thinking into our new

One OVD for all stages of cataract surgery

FR Pro is designed to protect the endothelium, provide excellent chamber maintenance and is fully validated with all Rayner IOL injectors. What’s more, the extra volume 1.2 ml syringe gives you the confidence that Ophteis FR Pro will support all elements of your cataract procedure.

Convenient and Easy-to-UseUnlike many OVDs, Rayner’s Ophteis FR Pro does not need to be refrigerated before use.With its stable rheology at room temperature you will enjoy consistent performance for every procedure.

We’ve done the thinking, the research and the testing. Now it’s time for you to see the benefits of Ophteis FR Pro for yourself.

Take the FR Pro Challenge, visit

rayner.com/frpro

A viscous cohesive for a SAFE environment

SEE THE DIFFERENCEPUT OUR THINKING TO THE TEST

EVERYTHING YOU’D EXPECT FROM YOUR OVD AND MORE

Through the bio-engineered composition of NaHA and sorbitol, Ophteis FR Pro is transformed into a viscous cohesive. It is stable in the anterior chamber during phaco, providing excellent chamber maintenance and is easy to remove at the end of surgery.

Page 4: OPHTEIS FR PRO THAT’S RADICAL THINKING€¦ · the use of Rayner’s Ophteis FR Pro reduces cell death by an average of 27.8%*. We’ve put a lot of fresh thinking into our new

addING Sorbitol to OVDs,

That’s radical thinking

GLOBAL HQ & UK OFFICERAYNER INTRAOCULAR LENSES LIMITEDThe Ridley Innovation Centre10 Dominion WayWorthing, West SussexBN14 8AQ. United Kingdom

Tel: +44 (0) 1903 258 900Email: [email protected]: rayner.com

UK CUSTOMER SERVICETel: +44 (0) 1903 854 560Email: [email protected]

GERMANY CUSTOMER SERVICETel: +49 30 6290783 - 0Email: [email protected]

©2017 Rayner Intraocular Lenses Limited. OPHTEIS a registered trade mark of Rayner.Regulatory restrictions may apply in certain markets. EC 2017-70 08/17